We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Roche spends $1 billion on Foundation Medicine's tumor profiling.
- Authors
Ratner, Mark
- Abstract
The article reports on the acquisition of a major stake in Cambridge, Massachusetts-based firm Foundation Medicine Inc., a laboratory that provides deep sequencing for individual patients' tumors, by Basel, Switzerland-based pharmaceutical F. Hoffmann-La Roche Ltd. The company states that it will spend more than a billion dollars for a majority interest in Foundation Medicine. It will also ante at least $150 million more as part of an research and development (R&D) collaboration.
- Subjects
BASEL (Switzerland); SWITZERLAND; CAMBRIDGE (Mass.); MASSACHUSETTS; F. Hoffmann-La Roche Ltd.; FOUNDATION Medicine Inc.; RESEARCH &; development; STAKEHOLDERS
- Publication
Nature Biotechnology, 2015, Vol 33, Issue 3, p215
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0315-215